Product Datasheet
Nicotinic Acetylcholine Receptor alpha 4 Antibody
Catalog Number: 35433
Technical:tech@swbio.com
Information:info@swbio.com
Description
- Swiss-Prot No.:
- Swiss-Prot#:P43681;
NCBI Gene#:1137
- Form of Antibody:
- Rabbit IgG in 0.1M Tris, 0.1M Glycine, 20% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.
- Immunogen:
- Recombinant fragment corresponding to a region within amino acids 53 and 280 of Nicotinic Acetylcholine Receptor alpha 4.
- appl_detail:
- Western blotting: 1:500-1:3000
- other_names:
- BFNC antibody; EBN antibody; EBN1 antibody; FLJ95812 antibody; NACHR antibody; NACHRA4 antibody; NACRA4 antibody; CHRNA4 antibody; neuronal nicotinic acetylcholine receptor alpha-4 subunit antibody; "cholinergic receptor; nicotinic; alpha polypeptide 4 an
- Purification:
- Antibodies were purified by antigen-affinity chromatography.
- Specificity:
- The antibody detects endogenous levels of total Nicotinic Acetylcholine Receptor alpha 4 protein.
- Background:
- This gene encodes a nicotinic acetylcholine receptor, which belongs to a superfamily of ligand-gated ion channels that play a role in fast signal transmission at synapses. These pentameric receptors can bind acetylcholine, which causes an extensive change in conformation that leads to the opening of an ion-conducting channel across the plasma membrane. This protein is an integral membrane receptor subunit that can interact with either nAChR beta-2 or nAChR beta-4 to form a functional receptor. Mutations in this gene cause nocturnal frontal lobe epilepsy type 1. Polymorphisms in this gene that provide protection against nicotine addiction have been described. [provided by RefSeq]
© Signalway Biotechnology All Rights Reserved.